KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $6.7 billion.

  • Eli Lilly's Free Cash Flow rose 18579.54% to $6.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 billion, marking a year-over-year increase of 56237.32%. This contributed to the annual value of $3.8 billion for FY2024, which is 37446.06% up from last year.
  • As of Q3 2025, Eli Lilly's Free Cash Flow stood at $6.7 billion, which was up 18579.54% from $1.4 billion recorded in Q2 2025.
  • Eli Lilly's Free Cash Flow's 5-year high stood at $6.7 billion during Q3 2025, with a 5-year trough of -$1.4 billion in Q4 2023.
  • For the 5-year period, Eli Lilly's Free Cash Flow averaged around $1.3 billion, with its median value being $1.2 billion (2023).
  • Per our database at Business Quant, Eli Lilly's Free Cash Flow surged by 102578.57% in 2021 and then plummeted by 21897.59% in 2023.
  • Quarter analysis of 5 years shows Eli Lilly's Free Cash Flow stood at $2.0 billion in 2021, then tumbled by 41.02% to $1.2 billion in 2022, then plummeted by 218.98% to -$1.4 billion in 2023, then skyrocketed by 170.73% to $977.8 million in 2024, then skyrocketed by 590.14% to $6.7 billion in 2025.
  • Its Free Cash Flow stands at $6.7 billion for Q3 2025, versus $1.4 billion for Q2 2025 and $156.1 million for Q1 2025.